Kozak & Associates’s iShares S&P 500 Growth ETF IVW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.1K Sell
483
-24
-5% -$3.17K 0.01% 132
2026
Q1
$62K Hold
507
0.01% 134
2025
Q4
$63.2K Buy
507
+1
+0.2% +$122 0.01% 133
2025
Q3
$60.8K Buy
506
+35
+7% +$4.03K 0.01% 137
2025
Q2
$52.2K Buy
471
+1
+0.2% +$99 0.01% 147
2025
Q1
$42.8K Hold
470
0.01% 137
2024
Q4
$48.5K Buy
470
+1
+0.2% +$100 0.01% 133
2024
Q3
$45.4K Buy
469
+1
+0.2% +$92 0.01% 136
2024
Q2
$44.4K Hold
468
0.01% 131
2024
Q1
$40.4K Buy
468
+1
+0.2% +$80 0.01% 140
2023
Q4
$35.4K Buy
467
+1
+0.2% +$71 0.01% 151
2023
Q3
$32.3K Buy
466
+1
+0.2% +$71 0.01% 164
2023
Q2
$32.8K Buy
465
+1
+0.2% +$66 0.01% 162
2023
Q1
$29.6K Buy
464
+2
+0.4% +$122 0.01% 174
2022
Q4
$27K Buy
462
+1
+0.2% +$60 0.01% 176
2022
Q3
$26K Buy
461
+1
+0.2% +$65 0.02% 176
2022
Q2
$28K Buy
460
+2
+0.4% +$132 0.02% 181
2022
Q1
$32K Hold
458
0.02% 187
2021
Q4
$32K Hold
458
0.02% 187
2021
Q3
$38K Buy
+458
New +$34.9K 0.02% 177

Other funds holding IVW

Kozak & Associates's IVW Position: Q2 2026 in Review

Kozak & Associates reduced its iShares S&P 500 Growth ETF (IVW) stake by 4.7% in Q2 2026, selling an estimated $3.17K and leaving 483 shares worth $66.1K. The position accounts for 0.01% of the portfolio, ranked #132.

Kozak & Associates first reported a position in IVW in Q3 2021 and has held it in 20 quarters since. 2,124 funds tracked by Wall St. Rank hold IVW as of Q2 2026.

  • Kozak & Associates held 483 shares of iShares S&P 500 Growth ETF worth $66.1K as of Q2 2026.
  • Kozak & Associates sold 24 iShares S&P 500 Growth ETF shares in Q2 2026, an estimated $3.17K.
  • iShares S&P 500 Growth ETF made up 0.01% of Kozak & Associates's portfolio in Q2 2026, its #132 holding.
  • Kozak & Associates first reported a position in iShares S&P 500 Growth ETF in Q3 2021 and has held it in 20 quarters since.
  • 2,124 funds tracked by Wall St. Rank held iShares S&P 500 Growth ETF as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.